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We report a 74-year-old man with Wernicke’s encephalopathy (WE) whose only prior illness was peptic ulcer disease. Upper
gastrointestinal endoscopy demonstrated gastric ulcer scars accompanied by marked deformity, without pathologic evidence of
malignancy. WE due to peptic ulcer disease in previous reports was substantially associated with thiamine deﬁciency due to
recurrent vomiting or surgical procedures. In our case, however, there was no history of vomiting or gastrointestinal surgery.
Besides, we thoroughly ruled out other known clinical settings related to WE. There is the possibility that peptic ulcer disease itself
provoked thiamine deﬁciency due to malabsorption.
1.Introduction
Wernicke’s encephalopathy (WE) is an acute neuropsychi-
atric syndrome characterized by nystagmus and ophthal-
moplegia, ataxia of gait, and mental confusion. It results
from thiamine (vitamin B1) deﬁciency and is observed
mainly in alcoholics. Here, we describe a case of non-
alcoholic WE in peptic ulcer disease. WE due to peptic ulcer
disease in previous reports was substantially associated with
thiamine deﬁciency due to recurrent vomiting or surgical
procedures; the mechanisms of thiamine deﬁciency after
surgical procedures include the occurrence of recurrent
vomiting, poor compliance with an adequate dietary intake,
and the reduced area of the gastrointestinal mucosa for
absorbing thiamine [1, 2]. In our case, however, there was no
history of vomiting or gastrointestinal surgery. We consider
that peptic ulcer disease itself provoked thiamine deﬁciency
due to malabsorption.
2.CaseReport
A 74-year-old man was admitted to our hospital with
subacute progression of diplopia, gait disturbance, and
mental status change. He began to notice slight diplopia
three months before admission, but he could work as a
carpenter until several weeks before admission. According
to his family members, he ate a balanced diet regularly and
had not consumed alcohol in recent years. His past medical
history was hemorrhagic gastric ulcer managed without
surgery two years earlier, and then intake of lansoprazole
was started. There was no history of vomiting lately. His
family history was unremarkable. On admission, he exhib-
ited mental sluggishness, disorientation, and anterograde
amnesia. Neurological examination showed ophthalmople-
gia, nystagmus, and ataxia. Blood tests demonstrated a low
thiamine concentration (12.7ng/mL; normal range 21.3–
81.9ng/mL). Results of other blood tests, including vitamins
B2, B6, B12, folic acid, nicotinic acid, complete blood count,
kidney and thyroid function, magnesium concentration,
CEA, CA19-9, and IgG anti-Helicobacter pylori antibody,
were normal. Brain magnetic resonance imaging (MRI)
showedsymmetricalhigh-intensitylesionsinthemedialtha-
lami, hypothalami, periaqueductal grey matter, and the ﬂoor
of the fourth ventricle on T2-weighted images and ﬂuid-
attenuated inversion recovery (FLAIR) images (Figure 1).
Computed tomography of the chest and abdomen was
unremarkable. Upper and lower gastrointestinal endoscopy
demonstrated gastric ulcer scars accompanied by marked
deformity (Figure 2). The duodenum and other parts of the
gut were normal.
Intravenous thiamine (up to 1500mg per day) was
immediately administered for suspected WE on admission,2 Case Reports in Medicine
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Figure 1: MRI-FLAIR images of the brain showed symmetrical high-intensity lesions (arrows) in the ﬂoor of the fourth ventricle (a),
periaqueductal grey matter (b), hypothalami (b), and medial thalami (c).
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Figure 2: Marked deformity and shortening of the gastric angle (arrowhead) and lesser curvature (arrow), and insuﬃcient distention of the
pyloric antrum on upper gastrointestinal endoscopy (a) and gastric ﬂuoroscopy (b).
and his consciousness, ocular manifestation and gait distur-
banceweremarkedlyimproved.However,disorientationand
anterograde amnesia remained, and over the next several
weeks he developed confabulation suggesting Korsakoﬀ’s
syndrome. Multiple and repetitive biopsies of the gastric
mucosa over the next two years showed chronic gastritis
without evidence of malignancy.
3. Discussion
The present patient was diagnosed as having WE based
on the low serum thiamine concentration, response of
neurological signs to parenteral thiamine administration,
and typical brain MRI ﬁndings. Clinical settings related to
WE described in previous reports were thoroughly ruled
out: chronic alcohol abuse and malnutrition; history of
gastrointestinal surgical procedures; unbalanced nutrition
including staple diet of polished rice; recurrent vomiting
or chronic diarrhea; cancer; systemic diseases such as renal
disease, hyperthyroidism, and chronic infectious febrile
diseases; magnesium depletion; the use of drugs causing WE
[1].
In general, thiamine is known to be absorbed in the
duodenum. However, SLC19A2, one of the high-aﬃnity
thiamine transporters, was reported to show greater expres-
sion in the stomach more than in the duodenum [3]. This
ﬁnding suggests that the stomach plays a more important
role in thiamine absorption than previously thought. Thus,
we consider that thiamine deﬁciency in this patient was dueCase Reports in Medicine 3
to thiamine malabsorption in the stomach involved with
severe gastric mucosal lesions.
Patients with peptic ulcer disease often receive a proton-
pump inhibitor (PPI). PPIs have been recognized to induce
hypomagnesemia [4], which can provoke WE by subopti-
mum thiamine phosphorylation [5]. Although the use of
PPIs should receive attention as a cause of WE, we do not
consider in this respect that the PPI therapy was related to
WE in our patient because the serum magnesium level was
normal. Meanwhile, the mechanism of thiamine absorption
in gastrointestinal lumen involves hydrogen cations, and the
regular use of antacids may interfere with the absorption
of thiamine though there has been no direct evidence [1].
Accordingly, we cannot completely deny the possibility that
the long-term PPI use induced thiamine deﬁciency in this
patient.
Since not every individual with a similar degree of
thiamine deﬁciency develops WE [1], genetic factors may
also be likely to contribute disease expression in our patient.
Some studies have shown that variations in genes coding
for transketolase and the high-aﬃnity thiamine transporters
areimplicated inthe pathophysiology ofWernicke-Korsakoﬀ
syndrome (WKS) [6–11]. In WKS, several genetic defects
might combine with environmental factors to produce
clinical manifestations when thiamine storage declines [1].
WE due to peptic ulcer disease in previous reports
was substantially associated with thiamine deﬁciency due to
recurrent vomiting or surgical procedures [1, 2]. This case
is diﬀerent in that respect, and there is the possibility that
peptic ulcer disease itself provoked thiamine deﬁciency due
to malabsorption. Indeed, it is unclear why only this case
developed WE despite the large number of patients with
pepticulcerdisease.However,cliniciansshouldkeepinmind
that WE can occur as a rare complication of peptic ulcer
disease because WE is a serious and preventable disease. We
wish to emphasize that occasional measurement of blood
thiamine levels is desirable in patients with severe gastric
mucosal lesions.
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